Palisade Bio (PALI) Shares Outstanding (Diluted Average) (2016 - 2026)

Palisade Bio (PALI) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $209.7 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 4271.97% year-over-year to $209.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $209.7 million (up 4271.97% YoY) and the FY2025 annual result came in at $55.7 million, up 3830.18% from the prior year.
• Shares Outstanding (Diluted Average) grew to $209.7 million in Q1 2026 per PALI's latest filing, from $55.7 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $209.7 million in Q1 2026 and bottomed at $287702.0 in Q1 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $974197.0 (2022), against an average of $17.0 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) plunged 91.95%; it then jumped 4271.97% in 2026.
• Tracing PALI's Shares Outstanding (Diluted Average) over 5 years: stood at $880311.0 in 2022, then sank by 48.2% to $456014.0 in 2023, then jumped by 210.62% to $1.4 million in 2024, then jumped by 3830.18% to $55.7 million in 2025, then jumped by 276.62% to $209.7 million in 2026.
• Per Business Quant, the three latest PALI Shares Outstanding (Diluted Average) figures stand at $209.7 million (Q1 2026), $55.7 million (Q4 2025), and $5.7 million (Q3 2025).

Peer Comparison